The development of lymphadenopathy after combining anti-TNF and anti-CD11a therapy and the prompt resolution of symptoms after their discontinuation, followed by lack of recurrence with using anti-TNF therapy alone, suggests that these drugs caused or facilitated the development of this process. Here, TNF is linked to Lymphadenopathy.